SHPH

Shuttle Pharmaceuticals Inc

SHPH.US shuttlepharma.com
3.50
-0.04 (-1.13%)
USD · NASDAQ
52-week range
2.58
55.90
Trading at 2% of the 52-week range
Market Cap
2.05M
P/E Ratio
35.00
Forward P/E
0.00
Book Value
6.03
Div. Yield
N/A
% Institutions
8.94%
% Insiders
3.91%

1 Year

-89.4%

3 Year

-99.7%

10 Year

-100.0%
Description

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Company Information

Company Name
Shuttle Pharmaceuticals Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US8256935003
CIK: 0001757499
CUSIP: 825693401
Currency: USD
Full Time Employees: 2
Phone: 240 403 4212
Fiscal Year End: December
IPO Date: Aug 31, 2022
Description:

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Address:

401 Professional Drive, Gaithersburg, MD, United States, 20879

People

Directors & Officers

Name Title Year Born
Mr. Christopher Robert Cooper BBA, M.B.A. Interim Co-CEO & Director 1970
Dr. Milton Brown CSC, M.D., Ph.D. Co-Founder 1965
Mr. Ryan Trasolini Co-Chief Executive Officer NA
Dr. Mira Jung Ph.D. Co-Founder & Chief Scientific Officer for Biology 1949
Ms. Yuying Liang B.A., CPA Chief Financial Officer 1991
Dr. Tyvin A. Rich M.D. Chief Clinical Officer & Chief Medical Officer 1948
Mr. Michael P. Vander Hoek Vice President for Operations and Regulatory 1960

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 13, 2023 Bette Jacobs N/A Sale 166.00 $11.50 $1.91K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Ikarian Capital, LLC 68.99K Mar 31, 2026 1.23% $0.00 0.00%
Geode Capital Management, LLC 46.22K Mar 31, 2026 0.83% $0.00 219.97%
BOOTHBAY FUND MANAGEMENT, LLC 20.36K Mar 31, 2026 0.36% $0.00 0.00%
Virtu Financial LLC 12.38K Mar 31, 2026 0.22% $0.00 0.00%
UBS Group AG 5.67K Mar 31, 2026 0.10% $0.00 -52.54%
Tower Research Capital LLC 4.64K Mar 31, 2026 0.08% $0.00 471.55%
Wall Street Access Asset Management, LLC 120.00 Jun 30, 2026 0.02% $0.00 100.00%
Morgan Stanley - Brokerage Accounts 27.00 Mar 31, 2026 0.00% $0.00 0.00%
Federation des caisses Desjardins du Quebec 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Citigroup Inc 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Bank of America Corp 0.00 Mar 31, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 3.79K 0.68% ▲ 0.00% Jul 31, 2026
2 NT Ext Equity Mkt Index Fund - NL 671.00 0.12% ▲ 0.00% Jun 30, 2026
3 NT Ext Equity Mkt Idx Fd - DC - NL - T2 487.00 0.09% ▲ 0.00% Jun 30, 2026
4 Spartan Total Market Index Pool A1 52.00 0.01% ▲ 0.00% Jul 31, 2026

Financial Highlights

Market Cap: $2.05M
EBITDA: $-10.89M
P/E Ratio: $35.00
Book Value: $6.03
Earnings/Share: $0.10
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -81.65%
ROE (TTM): -326.36%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $1.16M
Trailing P/E: 35.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 585.13K
Shares Float: 582.39K
% Insiders: 3.91%
% Institutions: 8.94%
Short % Float: 9.16%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-290.11K
Gross Profit
subtotal
$-290.11K
SG&A
adjust
$-7.86M
R&D
adjust
$-4.05M
Operating Income
subtotal
$-11.92M
Other / Non-Operating Items
adjust
$195.16K
Net Income
subtotal
$-11.72M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SHPH.US!